Clinical Trials Directory

Trials / Completed

CompletedNCT04990505

Microvascular Injury and Distal Thrombosis in COVID-19

Microvascular Injury With Secondary Edema, and Distal Peripheral Vascular Thrombosis Contribution to Clinical Deterioration of Non-critically Ill Patients Hospitalized for SARS-CoV-2 Pneumonia Without Evidence of Pulmonary Embolism: a Preliminary Prospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Centre Hospitalier Princesse Grace · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Investigators aimed to better understand the pathophysiology of SARS-CoV-2 pneumonia in non-critically ill hospitalized patients secondarily presenting with clinical deterioration and increase in oxygen requirement

Detailed description

Investigators plan to consecutively enrol 25 patients without clinical or biological evidence for superinfection, without left ventricular dysfunction and for whom a pulmonary embolism was discarded by computed tomography pulmonary angiography. Investigators will investigate lung ventilation and perfusion (LVP) by LVP scintigraphy, and, 24 hours later, left and right ventricular function by 99mTc-labelled albumin gated-blood-pool scintigraphy with late (60 mn) tomographic albumin images on the lungs to evaluate lung albumin retention that could indicate microvascular injuries with secondary edema

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTlung ventilation/perfusion scintigraphyChest CT-scan will be performed with blocked inspiration. Lung ventilation/perfusion scintigraphy imaging will be performed within 24hrs after CT pulmonary angiography, 410MBq of Technegas will be inhaled by patients and ventilation tomography performed thereafter. Then, 185MBq 99mTc-macroaggegates will be injected intravenously followed by the perfusion tomography. A combined CT acquisition will be performed. The day following lung ventilation/perfusion scintigraphy, 740MBq of Tc99m labeled albumin will be intravenously administered. Cardiac gated-blood-pool scintigraphy will be then performed in best septal left anterior oblique and left profile according to specific parameters. 45-60 min after injection, a non-gated tomographic acquisition over the lungs will be done, with the same parameters than for PS SPECT, resulting in a late albumin acquisition.

Timeline

Start date
2020-02-22
Primary completion
2021-10-18
Completion
2022-02-28
First posted
2021-08-04
Last updated
2022-03-23

Locations

1 site across 1 country: Monaco

Source: ClinicalTrials.gov record NCT04990505. Inclusion in this directory is not an endorsement.